Literature DB >> 12354364

Interferons as antiangiogenic agents.

Daniel J Lindner1.   

Abstract

Interferons (IFNs), pleiotropic cytokines that regulate antiviral, antitumor, apoptotic, and cellular immune responses, were the first endogenous antiangiogenic regulators identified. In a species-specific manner, IFNs inhibit secretion of such angiogenic factors as basic fibroblast growth factor from tumor cells. The antiangiogenic activity of IFNs is enhanced when they are combined with other antiangiogenic agents, such as tamoxifen and thalidomide.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12354364     DOI： 10.1007/s11912-002-0065-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  59 in total

1.  Successful treatment of infantile hemangiomas with interferon-alpha-2b.

Authors:  E Chang; A Boyd; C C Nelson; D Crowley; T Law; K M Keough; J Folkman; R A Ezekowitz; V P Castle
Journal:  J Pediatr Hematol Oncol       Date:  1997 May-Jun       Impact factor: 1.289

2.  Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases.

Authors:  Jennifer J Marler; Joshua B Rubin; Nikolaus S Trede; Susan Connors; Holcombe Grier; Joseph Upton; John B Mulliken; Judah Folkman
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

3.  Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells.

Authors:  R K Singh; M Gutman; N Llansa; I J Fidler
Journal:  J Interferon Cytokine Res       Date:  1996-08       Impact factor: 2.607

Review 4.  Angiogenesis in chronic myeloproliferative diseases.

Authors:  F Di Raimondo; G A Palumbo; S Molica; R Giustolisi
Journal:  Acta Haematol       Date:  2001       Impact factor: 2.195

5.  Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach.

Authors:  E Régulier; S Paul; M Marigliano; J Kintz; Y Poitevin; C Ledoux; D Roecklin; G Cauet; V Calenda; H E Homann
Journal:  Cancer Gene Ther       Date:  2001-01       Impact factor: 5.987

6.  Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha.

Authors:  Z Ma; H Qin; E N Benveniste
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

7.  Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10).

Authors:  D A Arenberg; E S White; M D Burdick; S R Strom; R M Strieter
Journal:  Cancer Immunol Immunother       Date:  2001-12       Impact factor: 6.968

8.  Actions of TNF and IFN-gamma on angiogenesis in vitro.

Authors:  N Sato; H Nariuchi; N Tsuruoka; T Nishihara; J G Beitz; P Calabresi; A R Frackelton
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

9.  Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta.

Authors:  D R Bielenberg; C D Bucana; R Sanchez; J B Mulliken; J Folkman; I J Fidler
Journal:  Int J Oncol       Date:  1999-03       Impact factor: 5.650

10.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728
View more
  22 in total

1.  Vasohibin: the feedback on a new inhibitor of angiogenesis.

Authors:  Robert S Kerbel
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

2.  Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-γ and p53 signaling.

Authors:  Mathew Sajish; Quansheng Zhou; Shuji Kishi; Delgado M Valdez; Mili Kapoor; Min Guo; Sunhee Lee; Sunghoon Kim; Xiang-Lei Yang; Paul Schimmel
Journal:  Nat Chem Biol       Date:  2012-04-15       Impact factor: 15.040

Review 3.  Pivotal role for decorin in angiogenesis.

Authors:  Hannu Järveläinen; Annele Sainio; Thomas N Wight
Journal:  Matrix Biol       Date:  2015-02-07       Impact factor: 11.583

4.  Regulation of apoptosis by type III interferons.

Authors:  W Li; A Lewis-Antes; J Huang; M Balan; S V Kotenko
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

5.  Intralesional administration of interferon A for the management of severe haemangiomas.

Authors:  C Kaselas; G Tsikopoulos; G Papouis; V Kaselas
Journal:  Pediatr Surg Int       Date:  2006-12-15       Impact factor: 1.827

6.  Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus.

Authors:  Mariana Bernadett Arregui; Gregorio Juan Mc Callum; Ignacio Smith; Marcela Solange Villaverde; Federico Javier Wolman; Alexandra Marisa Targovnik; María Victoria Miranda
Journal:  3 Biotech       Date:  2018-07-27       Impact factor: 2.406

7.  Differential growth and responsiveness to cancer therapy of tumor cells in different environments.

Authors:  Mohammad Alsaggar; Qian Yao; Houjian Cai; Dexi Liu
Journal:  Clin Exp Metastasis       Date:  2015-10-17       Impact factor: 5.150

Review 8.  Stem Cell-Based Immunomodulation After Stroke: Effects on Brain Repair Processes.

Authors:  Marieke C S Boshuizen; Gary K Steinberg
Journal:  Stroke       Date:  2018-05-03       Impact factor: 7.914

9.  Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme.

Authors:  Jeffrey J Olson; Ellen McKenzie; Megan Skurski-Martin; Zhaobin Zhang; Daniel Brat; Surasak Phuphanich
Journal:  J Neurooncol       Date:  2008-08-05       Impact factor: 4.130

10.  Possible angiogenic roles for claudin-4 in ovarian cancer.

Authors:  Jianghong Li; Srinivasulu Chigurupati; Rachana Agarwal; Mohamed R Mughal; Mark P Mattson; Kevin G Becker; William H Wood; Yongqing Zhang; Patrice J Morin
Journal:  Cancer Biol Ther       Date:  2009-10       Impact factor: 4.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.